CTXM ESBLs: molecular epidemiology of the current UK problem - PowerPoint PPT Presentation

1 / 20
About This Presentation
Title:

CTXM ESBLs: molecular epidemiology of the current UK problem

Description:

Northern Ireland. 41. S East. 2. London. 4. W Mids. 1 ... Rachel Pike, ARMRL. Dot James, ARMRL. UK microbiologists. vigilence. referring isolates to ARMRL ... – PowerPoint PPT presentation

Number of Views:148
Avg rating:3.0/5.0
Slides: 21
Provided by: bsac7
Category:

less

Transcript and Presenter's Notes

Title: CTXM ESBLs: molecular epidemiology of the current UK problem


1
CTX-M ESBLs molecular epidemiology of the
current UK problem
  • Neil Woodford BSc PhD MRCPath
  • Antibiotic Resistance Monitoring Reference
    Laboratory, SRMD - Colindale

2
CTX-M b-lactamases in the UK
  • 2000 First producer (Alobwede JAC 2003, 51, 470)
  • K. oxytoca, Leeds, CTX-M-09
  • 2001-2 First hospital outbreak (Brenwald JAC
    2003, 51, 195)
  • K. pneumoniae, Birmingham, CTX-M-25-like
  • 2002 Surveillance isolates (Mushtaq JAC 2003,
    52, 528-9)
  • 4 E. coli from 3 centres, CTX-M-15

3
Phylogeny of CTX-M ESBLs
4
ESBLs in UK E. coli 2003-4
  • increasing reference requests for ESBL
    confirmation in E.coli
  • most expressing phenotype consistent with CTX-M
    enzymes
  • including isolates from community-acquired UTIs
  • little recent hospital contact

5
17th July 2004 broadsheets discover CTX-M
6
ESBLs in UK E. coli 2003-4
  • aim of this study was characterisation of
  • isolates by PFGE (n 291 for this analysis)
  • blaCTX-M alleles by PCR / sequencing

7
PFGE analysis of CTX-M-producing E. coli
  • ?85 similarity to define strains
  • 65 isolates belonged to 5 major strains
  • representatives of all major strains serotype O25
  • epidemic strain A
  • 110 isolates, 6 centres
  • specific molecular characteristics
  • 4 other major strains
  • other isolates
  • many diverse strains
  • some small (intra-hospital) clusters

8
Local epidemiology varies between centres
9
Characterisation of blaCTX-M alleles
  • 291 isolates analysed
  • 279 (96) contained alleles encoding group 1
    enzymes
  • 12 contained alleles encoding group 9 enzymes
  • 25 group 1 alleles sequenced
  • 20 isolates from 17 centres blaCTX-M-15
    ISEcp1-like element
  • 4 isolates from 3 centres blaCTX-M-15
    ISEcp1-like IS26 elements
  • 1 isolate blaCTX-M-03 ISEcp1-like element

10
Disrupted blaCTX-M-15 in UK epidemic strain A
IS26 between the bla gene and its usual promoter
  • lower MICs of CTX and CTZ likely due to altered
    expression
  • PCR detection of this insertion
  • working marker for this strain in the reference
    laboratory

11
Rapid PCR screening for probable strain A isolates
  • amplify a 400-bp fragment
  • spans the IS26-blaCTX-M link
  • PFGE essential to confirm strain A
  • other products possible
  • care when interpreting
  • only the 400-bp band is consistent with strain A
  • distinct IS26-blaCTX-M links
  • IS26-IS26 false products

12
3D clustering of selected CTX-M-15-producing
strains
  • strains A, B, and D form distinct clusters
  • 2 other strains have IS26 linked to blaCTX-M-15
  • unrelated to strain A (TN17, from Paris, a
    minor UK strain)
  • an IS26-blaCTX-M link is not a general indicator
    of strain relatedness

13
Geometric mean MICs, mg/L UK CTX-M producers
Meropenem ertapenem also active
14
Geometric mean MICs, mg/L UK CTX-M producers
15
Community-acquired CTX-M-producing strains
  • 24 isolates, mainly from urines, referred as
    community-acquired or GP specimen
  • 12 referring centres
  • PFGE
  • diverse types, but including
  • strain A and all major strains
  • CTX-M enzymes
  • 67 produced CTX-M-15 / other group 1
  • 3 produced CTX-M-09-like
  • As multi-resistant as full collection

16
Producers of CTX-M-09-like enzymes
  • 12 producers from 9 centres
  • distinct strains, including
  • 3 isolates from centre 4, 2 isolates from centre
    43
  • unlinked emergence or horizontal transfer events ?

17
On-going work
  • confirm whether UK blaCTX-M alleles are
    plasmid-mediated
  • no transfer demonstrated to date (n 10
    isolates)
  • evidence of horizontal transfer events ?
  • further characterisation of strain A
  • how does IS26 influence cephalosporin MICs ?
  • does IS26 also affect gentamicin MIC, or is
    sensitivity an independent characteristic ?
  • what factors contribute to the strains success ?
  • how are O25 CTX-M-15-producing strains related ?
  • investigate possible common ancestry

18
Reading List
  • The UK situation
  • Munday et al. JAC 2004 (Sept. issue)
  • Woodford et al. JAC 2004 (Oct. issue)
  • Reviews
  • Bonnet. AAC 2004481-14
  • Walther-Rasmussen Hoiby. Can J Microbiol
    200450137-165

19
Summary
  • CTX-M-producing E. coli
  • a rapidly developing problem (01/09/04 518
    producers from 77 labs)
  • many produce CTX-M-15
  • also detected in Klebsiella, Enterobacter,
    Citrobacter and Proteus (01/09/04 66 producers
    from 23 labs)
  • complex epidemiology
  • spread of major strains between centres
  • local spread of major / minor strains
  • multiple strains referred from some centres
  • horizontal transfer of plasmids and / or
    integrons ?
  • overspill into the community
  • multi-resistance
  • implications for treatment of community-acquired
    UTIs

20
Acknowledgements
  • UK microbiologists
  • vigilence
  • referring isolates to ARMRL
  • Control strains PCR conditions
  • Guillaume Arlet
  • Laurent Poirel
  • Funding
  • Health Protection Agency
  • EU / FP6-funded COBRA project
  • SRMD
  • Elaina Ward, ARMRL
  • Liz Fagan, ARMRL
  • Edi Karisik, ARMRL
  • Polly Kaufmann, LHCAI
  • Jane Turton, LHCAI
  • Tom Cheasty, LEP
  • Marina Warner, ARMRL
  • Rachel Pike, ARMRL
  • Dot James, ARMRL
Write a Comment
User Comments (0)
About PowerShow.com